256 related articles for article (PubMed ID: 15823121)
1. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
[TBL] [Abstract][Full Text] [Related]
2. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
3. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
Chung GG; Yoon HH; Zerkowski MP; Ghosh S; Thomas L; Harigopal M; Charette LA; Salem RR; Camp RL; Rimm DL; Burtness BA
Cancer; 2006 Apr; 106(8):1677-84. PubMed ID: 16532435
[TBL] [Abstract][Full Text] [Related]
5. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
6. Microvessel density and VEGF/VEGF receptor status and their role in sarcomas of the pulmonary artery.
Gaumann AK; Schermutzki G; Mentzel T; Kirkpatrick CJ; Kriegsmann JB; Konerding MA
Oncol Rep; 2008 Feb; 19(2):309-18. PubMed ID: 18202776
[TBL] [Abstract][Full Text] [Related]
7. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
8. Uterine sarcomas.
Punnonen R; Lauslahti K; Pystynen P; Kauppila O
Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in uterine sarcoma.
Gadducci A
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
[TBL] [Abstract][Full Text] [Related]
10. Current concepts in the imaging of uterine sarcoma.
Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
[TBL] [Abstract][Full Text] [Related]
11. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability in uterine sarcomas.
Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
14. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study.
Le Page C; Almadani N; Turashvili G; Bataillon G; Portelance L; Provencher D; Mes-Masson AM; Gilks B; Hoang L; Rahimi K
Int J Gynecol Pathol; 2021 Sep; 40(5):487-494. PubMed ID: 33720083
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series.
Leath CA; Straughn JM; Conner MG; Barnes MN; Alvarez RD; Partridge EE; Huh WK
J Reprod Med; 2004 Feb; 49(2):71-5. PubMed ID: 15018431
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.
Gao Y; Meng H; Zhang Y; Jiao T; Hui N
Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958
[TBL] [Abstract][Full Text] [Related]
18. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
19. Uterine sarcomas 2013.
Sutton G
Gynecol Oncol; 2013 Jul; 130(1):3-5. PubMed ID: 23769183
[No Abstract] [Full Text] [Related]
20. Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Funder A; Karkkainen MJ; Tainola T; Sørensen AB; Pedersen FS; D'Amore F
Leuk Lymphoma; 2009 Oct; 50(10):1647-60. PubMed ID: 19701853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
